Skip to content

Beclinic

Active
Private limited companyfounded 2008active for 18 yearsBrusselsesteenweg 466, 3090 Overijse, BelgiumKBO/BCE: BE 0807.253.004

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
04-05
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 88 days before the deadline
2025
28-07
Gazette deed Company renamed from B.V.B.A. DR PLOVIER-DR CZUPPER to Beclinic
Change of role: Dr. PLOVIER Frank, plastische heelkunde, from manager to director · Incorporation · Shareholding23 points ▸
  • General meeting, 26-06-2025
  • Incorporation, 18-10-2008
  • Dr. PLOVIER Frank, plastische heelkunde holds 93 shares
  • PLOVIER Frank Renaud Dominique holds 93 shares
  • Amendment of the articles, mentioned 2 times in the deed
  • General meeting, “eenparigheid van stemmen, aanpassing statuten” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Capital conversion, “eigen vermogensrekening niet-opgevraagde inbrengen” (deed in Dutch)
  • Reserve release, “opheffen, middelen beschikbaar voor uitkering” (deed in Dutch)
  • Reserve release, “toekomstige bijstortingen van het in het verleden geplaatste kapitaal, opheffen” (deed in Dutch)
  • General meeting, “eenparigheid van stemmen, opheffing eigen vermogensrekeningen” (deed in Dutch)
  • Name change, Beclinic
  • The act holds 11 more points.

Open the act in the Belgian Official Gazette

10-07
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 21 days before the deadline
2024
31-12
Financial Highest result from 2018 to 2025net €960,541 ▲29.7%
The operating result of €1.3m and the net result of €960,541 are both a record.
31-12
Financial Equity above €2mequity €2.7m ▲55.2%
With a profit in every financial year since 2018, equity grows to €2.7m.
29-08
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 29 days late
2023
31-12
Financial Equity above €1mequity €1.7m ▲74.2%
With a profit in every financial year since 2018, equity grows to €1.7m.
22-08
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 22 days late
2022
19-08
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 19 days late
2021
31-12
Financial Equity above €500,000equity €557,474 ▲61.6%
With a profit in every financial year since 2018, equity grows to €557,474.
19-07
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 12 days before the deadline
2020
28-09
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 59 days late
Show earlier events
2019
22-07
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 9 days before the deadline
2018
19-09
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 50 days late
2017
25-08
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 25 days late
2008
29-10
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Beclinic was incorporated on 21 October 2008.1 Since 2025 the company has been called Beclinic.2 Total assets rose from €1.8m in 2018 to €4.9m in 2025 and headcount from 7 to 9.9 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 28-07-2025
  3. 3National Bank, annual accounts 2018 and 2025

Next steps